Dr. John Timothy Carmack, MD, MPH Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 618 Hospital Rd, Tappahannock, VA 22560 Phone: 804-443-6297 |
Randy Joe Ferrance, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 618 Hospital Rd, Tappahannock, VA 22560 Phone: 804-443-3311 Fax: 804-443-6150 |
Thomas Leo Cleary Iii, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 618 Hospital Rd, Tappahannock, VA 22560 Phone: 804-443-6297 Fax: 804-443-6150 |
Mr. Hunter E Shirey, P.A. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 300 Mt Clement Park Ste B, Tappahannock, VA 22560 Phone: 804-443-8670 Fax: 804-443-8675 |
Thomas Henderson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 618 Hospital Rd, Tappahannock, VA 22560 Phone: 908-963-1655 |
James Roane Dudley, M.D., MBA Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 618 Hospital Rd, Tappahannock, VA 22560 Phone: 804-443-8649 Fax: 804-443-6150 |
News Archive
A new study has found that sucking on a baby's pacifier is linked to lower IgE levels, an antibody that is increased in allergies and asthma.
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced its fiscal 2010 second quarter results for period ended June 30, 2010.
A burst appendix or a life-threatening intestinal volvulus are emergencies that need to be treated by surgeons immediately. However, a life-saving operation, in which tissue from the digestive tract has to be reattached, bears some risks. After all, everything that is transported through the gastrointestinal tract to the outside world in fact belongs there - and should under no circumstances end up inside the abdominal cavity.
Arena Pharmaceuticals, Inc. announced today Merck and Co., Inc.'s decision (through an affiliate) to discontinue development of MK-1903, an investigational niacin receptor agonist to treat atherosclerosis being developed under its research collaboration with Arena. Merck also informed Arena that the company will not continue the collaboration.
› Verified 1 days ago